Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion

AMERISAFE (NASDAQ:AMSF) Issues Earnings Results, Misses Expectations By $0.08 EPS

AMERISAFE logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • AMERISAFE reported quarterly EPS of $0.40, missing analysts’ consensus estimate of $0.48 by $0.08. The company posted a 14.00% net margin and 14.87% return on equity.
  • Shares fell 0.6% to $25.30 following the results, with the stock trading well below its 12-month high of $42.10.
  • Analyst sentiment remains mixed but leans toward “Hold”; AMERISAFE has a consensus price target of $35.67, while several firms recently lowered their targets or issued sell-related ratings.
  • MarketBeat previews top five stocks to own in November.

AMERISAFE (NASDAQ:AMSF - Get Free Report) posted its quarterly earnings results on Wednesday. The insurance provider reported $0.40 earnings per share for the quarter, missing analysts' consensus estimates of $0.48 by ($0.08), FiscalAI reports. AMERISAFE had a net margin of 14.00% and a return on equity of 14.87%.

AMERISAFE Stock Down 0.6%

Shares of AMSF traded down $0.16 during midday trading on Wednesday, reaching $25.30. 260,363 shares of the stock were exchanged, compared to its average volume of 291,009. AMERISAFE has a twelve month low of $23.20 and a twelve month high of $42.10. The company has a market cap of $469.06 million, a P/E ratio of 10.20 and a beta of 0.24. The stock's 50 day simple moving average is $25.08 and its 200 day simple moving average is $31.20.

Wall Street Analyst Weigh In

Several research firms have commented on AMSF. Wall Street Zen downgraded shares of AMERISAFE from a "hold" rating to a "sell" rating in a report on Tuesday, October 20th. Citizens Jmp cut their target price on shares of AMERISAFE from $42.00 to $40.00 and set a "market outperform" rating for the company in a research note on Monday, October 12th. Zacks Research raised shares of AMERISAFE from a "strong sell" rating to a "hold" rating in a report on Monday, September 28th. Weiss Ratings reissued a "sell (d+)" rating on shares of AMERISAFE in a report on Monday. Finally, Truist Financial cut their price objective on shares of AMERISAFE from $32.00 to $27.00 and set a "hold" rating for the company in a research report on Tuesday, October 13th. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, AMERISAFE presently has a consensus rating of "Hold" and an average target price of $35.67.

Get Our Latest Analysis on AMERISAFE

About AMERISAFE

(Get Free Report)

AMERISAFE, Inc is a specialty workers' compensation insurance company serving small and midsized businesses. The company focuses on employers in industries with elevated workplace risks, including construction, trucking, logging, agriculture, manufacturing, and maritime operations.

Through its insurance subsidiaries, AMERISAFE provides workers' compensation coverage designed to protect businesses from costs associated with workplace injuries and occupational illnesses. Its services also include workplace safety and loss-control support, claims management, medical cost containment, and premium audit services.

Headquartered in DeRidder, Louisiana, AMERISAFE primarily serves employers in the southeastern and south-central United States.

See Also

Earnings History for AMERISAFE (NASDAQ:AMSF)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AMERISAFE Right Now?

Before you consider AMERISAFE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.

While AMERISAFE currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines